{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:21:37Z","timestamp":1775168497124,"version":"3.50.1"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T00:00:00Z","timestamp":1460332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"DOI":"10.1007\/s13346-016-0290-2","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T08:28:29Z","timestamp":1460622509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies"],"prefix":"10.1007","author":[{"given":"Miloni","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brijesh","family":"S.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,11]]},"reference":[{"key":"290_CR1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/415670a","volume":"415","author":"B Greenwood","year":"2002","unstructured":"Greenwood B, Mutabingwa T. Malaria in 2002. Nature. 2002;415:670\u20132.","journal-title":"Nature"},{"key":"290_CR2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/524889","volume":"46","author":"NJ White","year":"2008","unstructured":"White NJ. Plasmodium knowlesi: the fifth human malaria parasite. Clin Infect Dis. 2008;46:172\u20133.","journal-title":"Clin Infect Dis"},{"key":"290_CR3","volume-title":"World malaria report","author":"The World Health Organization","year":"2015","unstructured":"The World Health Organization. World malaria report. Geneva: Switzerland; 2015. Accessed 15 July 2015."},{"key":"290_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1756-3305-3-117","volume":"3","author":"ME Sinka","year":"2010","unstructured":"Sinka ME, Bangs MJ, Manguin S, et al. The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East: occurrence data, distribution maps and bionomic pr\u00e9cis. Parasit Vectors. 2010;3:117\u201351.","journal-title":"Parasit Vectors"},{"key":"290_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0065-308X(05)61002-0","volume":"61","author":"P Winstanley","year":"2006","unstructured":"Winstanley P, Ward S. Malaria chemotherapy. Adv Parasitol. 2006;61:47\u201376.","journal-title":"Adv Parasitol"},{"key":"290_CR6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/EC.00314-10","volume":"10","author":"N Gerald","year":"2011","unstructured":"Gerald N, Mahajan B, Kumar S. Mitosis in the human malaria parasite Plasmodium falciparum. Eukaryot Cell. 2011;10:474\u20132.","journal-title":"Eukaryot Cell"},{"key":"290_CR7","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1086\/657120","volume":"51","author":"H Noedl","year":"2010","unstructured":"Noedl H, Se Y, Sriwichai S, et al. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin Infect Dis. 2010;51:e82\u20139.","journal-title":"Clin Infect Dis"},{"key":"290_CR8","doi-asserted-by":"crossref","unstructured":"RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386:31\u201345.","DOI":"10.1016\/S0140-6736(15)60721-8"},{"key":"290_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJM199107113250206","volume":"325","author":"AE Greenberg","year":"1991","unstructured":"Greenberg AE, Nsa W, Ryder RW, et al. Plasmodium falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire\u2014a prospective, longitudinal cohort study of 587 children. New En l J Med. 1991;325:105\u20139.","journal-title":"New En l J Med"},{"key":"290_CR10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/01.inf.0000101188.95433.60","volume":"22","author":"K Grimwade","year":"2003","unstructured":"Grimwade K, French N, Mbatha DD, Zungu DD, Dedicoat M, Gilks CF. Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence. Pediatr Infect Dis J. 2003;22:1057\u201363.","journal-title":"Pediatr Infect Dis J"},{"key":"290_CR11","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1172\/JCI33996","volume":"118","author":"BM Greenwood","year":"2008","unstructured":"Greenwood BM, Fidock DA, Kyle DE, et al. Malaria: progress, perils, and prospects for eradication. J Clin Invest. 2008;118:1266\u201376.","journal-title":"J Clin Invest"},{"key":"290_CR12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1461-5347(00)00255-8","volume":"3","author":"GM Barratt","year":"2000","unstructured":"Barratt GM. Therapeutic applications of colloidal drug carriers. Pharm Sci Technol Today. 2000;3:163\u201371.","journal-title":"Pharm Sci Technol Today"},{"key":"290_CR13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1166\/jbn.2007.038","volume":"3","author":"C Vauthier","year":"2007","unstructured":"Vauthier C, Couvreur P. Nanomedicines: a new approach for the treatment of serious diseases. J Biomed Nanotechnol. 2007;3:223\u201334.","journal-title":"J Biomed Nanotechnol"},{"key":"290_CR14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.addr.2008.02.013","volume":"60","author":"ML Forrest","year":"2008","unstructured":"Forrest ML, Kwon GS. Clinical developments in drug delivery nanotechnology. Adv Drug Deliv Rev. 2008;60:861\u20132.","journal-title":"Adv Drug Deliv Rev"},{"key":"290_CR15","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1128\/JCM.01022-08","volume":"46","author":"MK Sharma","year":"2008","unstructured":"Sharma MK, Rao VK, Agarwal GS, et al. Highly sensitive amperometric immunosensor for detection of Plasmodium falciparum histidine-rich protein 2 in serum of humans with malaria: comparison with a commercial kit. J Clin Microbiol. 2008;46:3759\u201365.","journal-title":"J Clin Microbiol"},{"key":"290_CR16","first-page":"83","volume":"160","author":"V Wiwanitkit","year":"2009","unstructured":"Wiwanitkit V. Alternative tools for field analysis on malarial infection: a reappraisal. Clin Ther. 2009;160:83\u20135.","journal-title":"Clin Ther"},{"key":"290_CR17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s10439-005-9020-5","volume":"34","author":"M Saltzman","year":"2006","unstructured":"Saltzman M, Desai T. Drug delivery in the BME curricula. Ann Biomed Eng. 2006;34:270\u20135.","journal-title":"Ann Biomed Eng"},{"key":"290_CR18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.copbio.2003.10.007","volume":"14","author":"G Orive","year":"2003","unstructured":"Orive G, Hern\u00e1ndez RM, Rodr\u00edguez Gasc\u00f3n A, Dom\u00ednguez-Gil A, Pedraz JL. Drug delivery in biotechnology: present and future. Curr Opin Biotechnol. 2003;14:659\u201364.","journal-title":"Curr Opin Biotechnol"},{"key":"290_CR19","first-page":"7","volume":"36","author":"J Zulueta de","year":"1994","unstructured":"de Zulueta J. Malaria and ecosystems: from prehistory to posteradication. Parassitologia. 1994;36:7\u201315.","journal-title":"Parassitologia"},{"key":"290_CR20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1472-8206.2009.00731.x","volume":"23","author":"B Uzzan","year":"2009","unstructured":"Uzzan B, Konate L, Diop A, et al. Efficacy of four repellents against mosquito bites: a double-blind randomized placebo-controlled field study in Senegal. Fundam Clin Pharmacol. 2009;23:589\u201394.","journal-title":"Fundam Clin Pharmacol"},{"key":"290_CR21","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1586\/14787210.5.6.1031","volume":"5","author":"F Castelli","year":"2007","unstructured":"Castelli F, Capone S, Pedruzzi B, Matteelli A. Antimicrobial prevention therapy for travelers\u2019 infection. Expert Rev Anti Infec Ther. 2007;5:1031\u201348.","journal-title":"Expert Rev Anti Infec Ther"},{"key":"290_CR22","unstructured":"The World Health Organization. International travel and health: situation as on 1 January 2010. WHO: Geneva, Switzerland, 2010. Accessed 15 July 2015."},{"key":"290_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.trstmh.2004.03.009","volume":"99","author":"SK Ghosh","year":"2005","unstructured":"Ghosh SK, Tiwari SN, Sathyanarayan TS, et al. Larvivorous fish in wells target the malaria vector sibling species of the Anopheles culicifacies complex in villages in Karnataka, India. Trans R Soc Trop Med Hyg. 2005;99:101\u20135.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"290_CR24","author":"X Gao","year":"2013","unstructured":"Gao X, Gunalan K, Yap SSL, Preiser PR. Triggers of key calcium signals during erythrocyte invasion by Plasmodium falciparum. Nat Commun. 2013. doi: 10.1038\/ncomms3862 .","journal-title":"Nat Commun"},{"key":"290_CR25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/424510","volume":"39","author":"K Leder","year":"2004","unstructured":"Leder K, Black J, O\u2019Brien D, et al. Malaria in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis. 2004;39:1104\u201312.","journal-title":"Clin Infect Dis"},{"key":"290_CR26","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa021592","volume":"349","author":"E Schwartz","year":"2003","unstructured":"Schwartz E, Parise M, Kozarsky P, Cetron M. Delayed onset of malaria-implications for chemoprophylaxis in travelers. N Engl J Med. 2003;349:1510\u20136.","journal-title":"N Engl J Med"},{"key":"290_CR27","unstructured":"Bruce-Chwatt. World Health Organization, technical meeting on chemotherapy of malaria. World Health Organization Technical Report Ser. 1961;226."},{"key":"290_CR28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(05)61510-3","volume":"352","author":"K Marsh","year":"1998","unstructured":"Marsh K. Malaria disaster in Africa. Lancet. 1998;352:924\u20135.","journal-title":"Lancet"},{"key":"290_CR29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1473-3099(03)00657-1","volume":"3","author":"EL Korenromp","year":"2003","unstructured":"Korenromp EL, Williams BG, Gouws E, Dye C, Snow RW. Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis. 2003;3:349\u201358.","journal-title":"Lancet Infect Dis"},{"key":"290_CR30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0035-9203(96)90129-7","volume":"90","author":"AM Ronn","year":"1996","unstructured":"Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg. 1996;90:179\u201381.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"290_CR31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1471-4922(01)02085-2","volume":"17","author":"CH Sibley","year":"2001","unstructured":"Sibley CH, Hyde JE, Sims PF, et al. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 2001;17:582\u20138.","journal-title":"Trends Parasitol"},{"key":"290_CR32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0140-6736(00)02505-8","volume":"356","author":"F Nosten","year":"2000","unstructured":"Nosten F, van Vugt M, Price R, et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet. 2000;356:297\u2013302.","journal-title":"Lancet"},{"key":"290_CR33","unstructured":"The World Health Organization. Antimalarial drug combination therapy. Report of a technical consultation. Geneva, Switzerland. WHO\/CDS\/RBM 2001.35. 2001."},{"key":"290_CR34","volume-title":"Status report on artemisinin resistance","author":"The World Health Organization","year":"2014","unstructured":"The World Health Organization. Status report on artemisinin resistance. Geneva: Switzerland; 2014."},{"key":"290_CR35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0140-6736(93)92568-E","volume":"341","author":"GS Murphy","year":"1993","unstructured":"Murphy GS. Basri H, Purnomo, Andersen EM, Bangs MJ, Mount DL, Gorden J, Lal AA, Purwokusumo AR, Harjosuwarno S, K. Sorensen, Hoffman SL. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet. 1993;341:96\u2013100.","journal-title":"Lancet"},{"key":"290_CR36","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/00034989760338","volume":"91","author":"S Looareesuwan","year":"1997","unstructured":"Looareesuwan S, Buchachart K, Wilairatana P, et al. Primaquine-tolerant vivax malaria in Thailand. Ann Trop Med Parasitol. 1997;91:939\u201343.","journal-title":"Ann Trop Med Parasitol"},{"key":"290_CR37","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"NJ White","year":"2004","unstructured":"White NJ. Antimalarial drug resistance. J Clin Invest. 2004;113:1084\u201392.","journal-title":"J Clin Invest"},{"key":"290_CR38","unstructured":"Bloland PB. Drug resistance in malaria. World Health Organization. WHO\/CDS\/CSR\/DRS\/2001.4. 2001."},{"key":"290_CR39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/499291a","volume":"499","author":"NL Komarova","year":"2013","unstructured":"Komarova NL, Boland RC. Cancer: calculated treatment. Nature. 2013;499:291\u20132.","journal-title":"Nature"},{"key":"290_CR40","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1086\/512743","volume":"1077","author":"CP Plowe","year":"2007","unstructured":"Plowe CP. Combination therapy for malaria: mission accomplished? Clin Infect Dis. 2007;1077:1075\u20137.","journal-title":"Clin Infect Dis"},{"key":"290_CR41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","volume":"62","author":"NS Santos-Magalh\u00e3es","year":"2010","unstructured":"Santos-Magalh\u00e3es NS, Mosqueira VCF. Nanotechnology applied to the treatment of malaria. Adv Drug Deliv Rev. 2010;62:560\u201375.","journal-title":"Adv Drug Deliv Rev"},{"key":"290_CR42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.addr.2009.11.010","volume":"62","author":"A Sosnik","year":"2010","unstructured":"Sosnik A, Amiji M. Nanotechnology solutions for infectious diseases in developing nations. Adv Drug Deliv Rev. 2010;62:375\u20137.","journal-title":"Adv Drug Deliv Rev"},{"key":"290_CR43","author":"D Parashar","year":"2014","unstructured":"Parashar D, Nayak AP, Murthy RSR. Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity. Drug Deliv. 2014. doi: 10.3109\/10717544.2014.905883 .","journal-title":"Drug Deliv"},{"key":"290_CR44","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0035-9203(00)90082-8","volume":"94","author":"M Vugt Van","year":"2000","unstructured":"Van Vugt M, Looareesuwan S, Wilairatana P, et al. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94:545\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"290_CR45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.exppara.2012.04.010","volume":"131","author":"AP Nayak","year":"2012","unstructured":"Nayak AP, Chimote G, Gunalan K, Banerjee R, Patankar S, Madhusudhan B. Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice. Exp Parasitol. 2012;131:292\u20139.","journal-title":"Exp Parasitol"},{"key":"290_CR46","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbrc.2004.11.051","volume":"326","author":"RC Reddy","year":"2005","unstructured":"Reddy RC, Vathsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN. Curcumin for malaria therapy. Biochem Biophys Res Commun. 2005;326:472\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"290_CR47","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0022-3565(24)36728-X","volume":"281","author":"J Golenser","year":"1997","unstructured":"Golenser J, Domb A, Teomim D, et al. The treatment of animal models of malaria with iron chelators by use of a novel polymeric device for slow drug release. J Pharmacol Exp Ther. 1997;281:1127\u201335.","journal-title":"J Pharmacol Exp Ther"},{"key":"290_CR48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0168-3659(91)90038-F","volume":"161","author":"DJA Crommelin","year":"1991","unstructured":"Crommelin DJA, Eling WMC, Steerenberg PA, et al. Liposome and immunoliposome for controlled release or site specific delivery of anti-parasitic drugs and cytostatics. J Control Rel. 1991;161:147\u201354.","journal-title":"J Control Rel"},{"key":"290_CR49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.intimp.2008.01.008","volume":"8","author":"C Varalakshmi","year":"2008","unstructured":"Varalakshmi C, Mubarak AA, Pardhasaradhi BVV, Srivastava RM, Singh S, Khar A. Immunomodulatory effects of curcumin: in-vivo. Int Immunopharmacol. 2008;8:688\u2013700.","journal-title":"Int Immunopharmacol"},{"key":"290_CR50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2567.1998.00479.x","volume":"94","author":"W Bordmann","year":"1998","unstructured":"Bordmann W, Rudin NF. Immunization of mice with phosphatidylcholine drastically reduces the parasitemia of subsequent Plasmodium chabaudi chabaudi blood-stage infections. Immunology. 1998;94:35\u201340.","journal-title":"Immunology"},{"key":"290_CR51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0005-2736(82)90178-X","volume":"687","author":"S Kutner","year":"1982","unstructured":"Kutner S, Baruch D, Ginsburg H, Cabantchik ZI. Alterations in membrane permeability of malaria-infected human erythrocytes are related to the growth stage of the parasite. Biochim Biophys Acta. 1982;687:113\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"290_CR52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pt.2005.05.013","volume":"21","author":"GA Biagini","year":"2005","unstructured":"Biagini GA, Ward SA, Bray PG. Malaria parasite transporters as a drug-delivery strategy. Trends Parasitol. 2005;21:299\u2013301.","journal-title":"Trends Parasitol"},{"key":"290_CR53","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/252718a0","volume":"252","author":"CA Homewood","year":"1974","unstructured":"Homewood CA, Neame KD. Malaria and the permeability of the host erythrocyte. Nature. 1974;252:718\u20139.","journal-title":"Nature"},{"key":"290_CR54","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1016\/S0021-9258(17)41868-0","volume":"269","author":"K Kirk","year":"1994","unstructured":"Kirk K, Horner HA, Elford BC, Ellory JC, Newbold CI. Transport of diverse substrates into malaria infected erythrocytes via a pathway showing functional characteristics of a chloride channel. J Biol Chem. 1994;269:3339\u201347.","journal-title":"J Biol Chem"},{"key":"290_CR55","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/35023000","volume":"406","author":"SA Desai","year":"2000","unstructured":"Desai SA, Bezrukov SM, Zimmerberg J. A voltage-dependent channel involved in nutrient uptake by red blood cells infected with the malaria parasite. Nature. 2000;406:1001\u20135.","journal-title":"Nature"},{"key":"290_CR56","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","volume":"419","author":"MJ Gardner","year":"2002","unstructured":"Gardner MJ, Hall N, Fung E, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 2002;419:498\u2013511.","journal-title":"Nature"},{"key":"290_CR57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s000180300002","volume":"60","author":"G Barratt","year":"2003","unstructured":"Barratt G. Colloidal drug carriers: achievements and perspectives. Cell Mol Life Sci. 2003;60:21\u201337.","journal-title":"Cell Mol Life Sci"},{"key":"290_CR58","first-page":"594","volume":"19","author":"DD Lasic","year":"1991","unstructured":"Lasic DD, Martin FJ, Mayhew E. Stealth liposomes. Ann Biomed Eng. 1991;19:594.","journal-title":"Ann Biomed Eng"},{"key":"290_CR59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0169-409X(95)00026-4","volume":"16","author":"R Gref","year":"1995","unstructured":"Gref R, Domb A, Quellec P, et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev. 1995;16:215\u201333.","journal-title":"Adv Drug Deliv Rev"},{"key":"290_CR60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0169-409X(01)00227-7","volume":"53","author":"MC Garnett","year":"2001","unstructured":"Garnett MC. Targeted drug conjugates: principles and progress. Adv Drug Deliv Rev. 2001;53:171\u2013216.","journal-title":"Adv Drug Deliv Rev"},{"key":"290_CR61","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(96)00457-7","volume":"24","author":"GL Scherphof","year":"1997","unstructured":"Scherphof GL, Velinova M, Kamps J, et al. Modulation of pharmacokinetic behavior of liposomes. Adv Drug Deliv Rev. 1997;24:179\u201391.","journal-title":"Adv Drug Deliv Rev"},{"key":"290_CR62","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/(SICI)1097-4636(19980305)39:3<478::AID-JBM19>3.0.CO;2-6","volume":"39","author":"M L\u00fcck","year":"1998","unstructured":"L\u00fcck M, Paulke BR, Schr\u00f6der W, Blunk T, M\u00fcller RH. Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. J Biomed Mater Res. 1998;39:478\u201385.","journal-title":"J Biomed Mater Res"},{"key":"290_CR63","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","volume":"58","author":"VP Torchilin","year":"2006","unstructured":"Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev. 2006;58:1532\u201355.","journal-title":"Adv Drug Deliv Rev"},{"key":"290_CR64","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2011.01.001","volume":"151","author":"P Urb\u00e1n","year":"2011","unstructured":"Urb\u00e1n P, Estelrich J, Cort\u00e9s A, Fern\u00e0ndez-Busquets X. A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro. J Control Release. 2011;151:202\u201311.","journal-title":"J Control Release"},{"key":"290_CR65","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11095-006-9609-x","volume":"23","author":"KJ Longmuir","year":"2006","unstructured":"Longmuir KJ, Robertson RT, Haynes SM, Baratta JL, Waring AJ. Effective targeting of liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid sequence. Pharm Res. 2006;23:759\u201369.","journal-title":"Pharm Res"},{"key":"290_CR66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10717540802006211","volume":"15","author":"SM Haynes","year":"2008","unstructured":"Haynes SM, Longmuir KJ, Robertson RT, Baratta JL, Waring AJ. Liposomal polyethyleneglycol and polyethyleneglycol-peptide combinations for active targeting to liver in vivo. Drug Deliv. 2008;15:207\u201317.","journal-title":"Drug Deliv"},{"key":"290_CR67","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/AAC.39.1.180","volume":"39","author":"M Owais","year":"1995","unstructured":"Owais M, Varshney GC, Choudhury A, Chandra S, Gupta CM. Chloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice. Antimicrob Agents Chemother. 1995;39:180\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"290_CR68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(99)00061-7","volume":"41","author":"AK Agrawal","year":"2000","unstructured":"Agrawal AK, Gupta CM. Tuftsin-bearing liposomes in treatment of macrophage-based infections. Adv Drug Deliv Rev. 2000;41:135\u201346.","journal-title":"Adv Drug Deliv Rev"},{"key":"290_CR69","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1211\/jpp.59.7.0004","volume":"59","author":"Y Gupta","year":"2007","unstructured":"Gupta Y, Jain A, Jain SK. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol. 2007;59:935\u201340.","journal-title":"J Pharm Pharmacol"},{"key":"290_CR70","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1073\/pnas.91.15.7114","volume":"91","author":"R Polt","year":"1994","unstructured":"Polt R, Porreca F, Szabo LZ, et al. Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood\u2013brain barrier. Proc Natl Acad Sci U S A. 1994;91:7114\u201318.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"290_CR71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/1567201043334542","volume":"1","author":"Y Chen","year":"2004","unstructured":"Chen Y, Dalwadi G, Benson HA. Drug delivery across the blood\u2013brain barrier. Curr Drug Deliv. 2004;1:361\u201376.","journal-title":"Curr Drug Deliv"},{"key":"290_CR72","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"RH Muller","year":"2000","unstructured":"Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161\u201377.","journal-title":"Eur J Pharm Biopharm"},{"key":"290_CR73","first-page":"171","volume":"66","author":"D Pandita","year":"2011","unstructured":"Pandita D, Ahuja A, Lather V, Dutta T, Velpandian T, Khar RK. Development, characterization and in vitro assessment of stearylamine-based lipid nanoparticles of paclitaxel. Pharmazie. 2011;66:171\u20137.","journal-title":"Pharmazie"},{"key":"290_CR74","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","volume":"45","author":"A Muhlen zur","year":"1998","unstructured":"zur Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014drug release and release mechanism. Eur J Pharm Biopharm. 1998;45:149\u201355.","journal-title":"Eur J Pharm Biopharm"},{"key":"290_CR75","first-page":"267","volume":"56","author":"JE Diederichs","year":"1994","unstructured":"Diederichs JE, Muller RH. Liposomes in cosmetics and pharmaceutical products. Pharm Ind. 1994;56:267\u201375.","journal-title":"Pharm Ind"},{"key":"290_CR76","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-5173(98)00092-1","volume":"168","author":"C Freitas","year":"1998","unstructured":"Freitas C, Muller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles (SLN) dispersions. Int J Pharm. 1998;168:221\u20139.","journal-title":"Int J Pharm"},{"key":"290_CR77","unstructured":"Bucior I, Burger MM, Fern\u00e0ndez-Busquets X. Carbohydrate-carbohydrate interactions. In: The Sugar Code, Gabius, H.-J., Ed.; WILEY-VCH Verlag GmbH & Co. KGaA: Weinheim, 2009;347\u2013362."},{"key":"290_CR78","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/236147a0","volume":"236","author":"PJ Winterburn","year":"1972","unstructured":"Winterburn PJ, Phelps CF. The significance of glycosylated proteins. Nature. 1972;236:147\u201351.","journal-title":"Nature"},{"key":"290_CR79","unstructured":"Sol\u00eds D, Romero A, Men\u00e9ndez M, Jim\u00e9nez-Barbero J. Protein-carbohydrate interactions: basic concepts and methods for analysis. In: The Sugar Code, Gabius, H.-J., Ed.; WILEY-VCH Verlag GmbH & Co. KGaA: Weinheim, 2009; pp 233\u201345."},{"key":"290_CR80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-6851(01)00275-4","volume":"115","author":"A Craig","year":"2001","unstructured":"Craig A, Scherf A. Molecules on the surface of the Plasmodium falciparum infected erythrocyte and their role in malaria pathogenesis and immune evasion. Mol Biochem Parasitol. 2001;115:129\u201343.","journal-title":"Mol Biochem Parasitol"},{"key":"290_CR81","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1474-4422(05)70247-7","volume":"4","author":"R Idro","year":"2005","unstructured":"Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005;4:827\u201340.","journal-title":"Lancet Neurol"},{"key":"290_CR82","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1073\/pnas.98.4.1805","volume":"98","author":"A Pain","year":"2001","unstructured":"Pain A, Ferguson DJP, Kai O, et al. Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc Natl Acad Sci U S A. 2001;98:1805\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"290_CR83","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1182\/blood.V79.3.798.798","volume":"79","author":"GB Nash","year":"1992","unstructured":"Nash GB, Cooke BM, Marsh K, Berendt A, Newbold C, Stuart J. Rheological analysis of the adhesive interactions of red blood cells parasitized by Plasmodium falciparum. Blood. 1992;79:798\u2013807.","journal-title":"Blood"},{"key":"290_CR84","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1073\/pnas.93.8.3497","volume":"93","author":"DI Baruch","year":"1996","unstructured":"Baruch DI, Gormley JA, Ma C, Howard RJ, Pasloske BL. Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A. 1996;93:3497\u2013502.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"290_CR85","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0923-2494(96)81042-X","volume":"146","author":"C Robert","year":"1995","unstructured":"Robert C, Pouvelle B, Meyer P, et al. Chondroitin-4-sulphate (proteoglycan), a receptor for Plasmodium falciparum-infected erythrocyte adherence on brain microvascular endothelial cells. Res Immunol. 1995;146:383\u201393.","journal-title":"Res Immunol"},{"key":"290_CR86","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1182\/blood.V88.10.4040.bloodjournal88104040","volume":"88","author":"BM Cooke","year":"1996","unstructured":"Cooke BM, Rogerson SJ, Brown GV, Coppel RL. Adhesion of malaria-infected red blood cells to chondroitin sulfate A under flow conditions. Blood. 1996;88:4040\u20134.","journal-title":"Blood"},{"key":"290_CR87","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0166-6851(97)00082-0","volume":"88","author":"J Gysin","year":"1997","unstructured":"Gysin J, Pouvelle B, Le Tonqu\u00e8ze M, Edelman L, Boffa MC. Chondroitin sulfate of thrombomodulin is an adhesion receptor for Plasmodium falciparum-infected erythrocytes. Mol Biochem Parasitol. 1997;88:267\u201371.","journal-title":"Mol Biochem Parasitol"},{"key":"290_CR88","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1128\/IAI.66.10.4950-4956.1998","volume":"66","author":"B Pouvelle","year":"1998","unstructured":"Pouvelle B, Fusa\u00ef T, L\u00e9polard C, Gysin J. Biological and biochemical characteristics of cytoadhesion of Plasmodium falciparum-infected erythrocytes to chondroitin-4-sulfate. Infect Immun. 1998;66:4950\u20136.","journal-title":"Infect Immun"},{"key":"290_CR89","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1073\/pnas.96.9.5198","volume":"96","author":"JC Reeder","year":"1999","unstructured":"Reeder JC, Cowman AF, Davern KM, et al. The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1. Proc Natl Acad Sci U S A. 1999;96:5198\u2013202.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"290_CR90","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/blood.V96.1.327","volume":"96","author":"CJ McCormick","year":"2000","unstructured":"McCormick CJ, Newbold CI, Berendt AR. Sulfated glycoconjugates enhance CD36-dependent adhesion of Plasmodium falciparum-infected erythrocytes to human microvascular endothelial cells. Blood. 2000;96:327\u201333.","journal-title":"Blood"},{"key":"290_CR91","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1182\/blood.V95.11.3594","volume":"95","author":"A Barragan","year":"2000","unstructured":"Barragan A, Fernandez V, Chen Q, von Euler A, Wahlgren M, Spillmann D. The duffy-binding-like domain 1 of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a heparin sulfate ligand that requires 12 mers for binding. Blood. 2000;95:3594\u20139.","journal-title":"Blood"},{"key":"290_CR92","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1182\/blood-2002-07-2016","volume":"101","author":"AM Vogt","year":"2003","unstructured":"Vogt AM, Barragan A, Chen Q, Kironde F, Spillmann D, Wahlgren M. Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1\u03b1 domain of PfEMP1. Blood. 2003;101:2405\u201311.","journal-title":"Blood"},{"key":"290_CR93","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1126\/science.2467377","volume":"243","author":"CF Ockenhouse","year":"1989","unstructured":"Ockenhouse CF, Tandon NN, Magowan C, Jamieson GA, Chulay JD. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Science. 1989;243:1469\u201371.","journal-title":"Science"},{"key":"290_CR94","doi-asserted-by":"crossref","first-page":"22426","DOI":"10.1074\/jbc.M700231200","volume":"282","author":"JG Beeson","year":"2007","unstructured":"Beeson JG, Andrews KT, Boyle M, et al. Structural basis for binding of Plasmodium falciparum erythrocyte membrane protein 1 to chondroitin sulfate and placental tissue and the influence of protein polymorphisms on binding specificity. J Biol Chem. 2007;282:22426\u201336.","journal-title":"J Biol Chem"},{"key":"290_CR95","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1126\/science.272.5267.1502","volume":"272","author":"M Fried","year":"1996","unstructured":"Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science. 1996;272:1502\u201304.","journal-title":"Science"},{"key":"290_CR96","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1128\/IAI.00478-07","volume":"75","author":"SV Madhunapantula","year":"2007","unstructured":"Madhunapantula SV, Achur RN, Gowda DC. Developmental stage- and cell cycle number-dependent changes in characteristics of Plasmodium falciparum-infected erythrocyte adherence to placental chondroitin-4-sulfate proteoglycan. Infect Immun. 2007;75:4409\u201315.","journal-title":"Infect Immun"},{"key":"290_CR97","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.2353\/ajpath.2007.061238","volume":"170","author":"A Muthusamy","year":"2007","unstructured":"Muthusamy A, Achur RN, Valiyaveettil M, et al. Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta, and infected red blood cell adherence up-regulates the receptor expression. Am J Pathol. 2007;170:1989\u20132000.","journal-title":"Am J Pathol"},{"key":"290_CR98","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nsmb.1479","volume":"15","author":"K Singh","year":"2008","unstructured":"Singh K, Gittis AG, Nguyen P, Gowda DC, Miller LH, Garboczi DN. Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A. Nat Struct Mol Biol. 2008;15:932\u20138.","journal-title":"Nat Struct Mol Biol"},{"key":"290_CR99","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molbiopara.2009.12.008","volume":"170","author":"A Juillerat","year":"2010","unstructured":"Juillerat A, Igonet S, Vigan-Womas I, et al. Biochemical and biophysical characterisation of DBL1\u03b11-varO, the rosetting domain of PfEMP1 from the VarO line of Plasmodium falciparum. Mol Biochem Parasitol. 2010;170:84\u201392.","journal-title":"Mol Biochem Parasitol"},{"key":"290_CR100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.187.1.15","volume":"187","author":"Q Chen","year":"1998","unstructured":"Chen Q, Barragan A, Fernandez V, et al. Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. J Exp Med. 1998;187:15\u201323.","journal-title":"J Exp Med"},{"key":"290_CR101","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/expr.1998.4349","volume":"91","author":"A Barragan","year":"1999","unstructured":"Barragan A, Spillmann D, Kremsner PG, Wahlgren M, Carlson J. Plasmodium falciparum: molecular background to strainspecific rosette disruption by glycosaminoglycans and sulfated glycoconjugates. Exp Parasitol. 1999;91:133\u201343.","journal-title":"Exp Parasitol"},{"key":"290_CR102","doi-asserted-by":"crossref","first-page":"21824","DOI":"10.1074\/jbc.M401979200","volume":"279","author":"JB Ancsin","year":"2004","unstructured":"Ancsin JB, Kisilevsky R. A binding site for highly sulphated heparan sulfate is identified in the N terminus of the circumsporozoite protein: significance for malarial sporozoite attachment to hepatocytes. J Biol Chem. 2004;279:21824\u201332.","journal-title":"J Biol Chem"},{"key":"290_CR103","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1083\/jcb.117.6.1351","volume":"117","author":"SJ Pancake","year":"1992","unstructured":"Pancake SJ, Holt GD, Mellouk S, Hoffman SL. Malaria sporozoites and circumsporozoite proteins bind specifically to sulphated glycoconjugates. J Cell Biol. 1992;117:1351\u20137.","journal-title":"J Cell Biol"},{"key":"290_CR104","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1084\/jem.177.5.1287","volume":"177","author":"U Frevert","year":"1993","unstructured":"Frevert U, Sinnis P, Cerami C, Shreffler W, Takacs B, Nussenzweig V. Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes. J Exp Med. 1993;177:1287\u201398.","journal-title":"J Exp Med"},{"key":"290_CR105","doi-asserted-by":"crossref","first-page":"26784","DOI":"10.1074\/jbc.M104038200","volume":"276","author":"C Pinzon-Ortiz","year":"2001","unstructured":"Pinzon-Ortiz C, Friedman J, Esko J, Sinnis P. The binding of the circumsporozoite protein to cell surface heparan sulfate proteoglycans is required for Plasmodium sporozoite attachment to target cells. J Biol Chem. 2001;276:26784\u201391.","journal-title":"J Biol Chem"},{"key":"290_CR106","doi-asserted-by":"crossref","first-page":"11518","DOI":"10.1021\/bi0105476","volume":"40","author":"D Rathore","year":"2001","unstructured":"Rathore D, McCutchan TF, Garboczi DN, et al. Direct measurement of the interactions of glycosaminoglycans and a heparin decasaccharide with the malaria circumsporozoite protein. Biochemistry. 2001;40:11518\u201324.","journal-title":"Biochemistry"},{"key":"290_CR107","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1182\/blood-2009-09-243725","volume":"115","author":"MJ Boyle","year":"2010","unstructured":"Boyle MJ, Richards JS, Gilson PR, Chai W, Beeson JG. Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites. Blood. 2010;115:4559\u201368.","journal-title":"Blood"},{"key":"290_CR108","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1128\/IAI.73.7.4288-4294.2005","volume":"73","author":"KT Andrews","year":"2005","unstructured":"Andrews KT, Klatt N, Adams Y, Mischnick P, Schwartz-Albiez R. Inhibition of chondroitin-4-sulfate-specific adhesion of Plasmodium falciparum-infected erythrocytes by sulfated polysaccharides. Infect Immun. 2005;73:4288\u201394.","journal-title":"Infect Immun"},{"key":"290_CR109","author":"AM Vogt","year":"2006","unstructured":"Vogt AM, Pettersson F, Moll K, et al. Release of sequestered malaria parasites upon injection of a glycosaminoglycan. PLoS Pathog. 2006. doi: 10.1371\/journal.ppat.0020100 .","journal-title":"PLoS Pathog"},{"key":"290_CR110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4269\/ajtmh.2011.10-0256","volume":"84","author":"AM Leitgeb","year":"2011","unstructured":"Leitgeb AM, Blomqvist K, Cho-Ngwa F, et al. Low anticoagulant heparin disrupts Plasmodium falciparum rosettes in fresh clinical isolates. Am J Trop Med Hyg. 2011;84:390\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"290_CR111","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4269\/ajtmh.1992.46.595","volume":"46","author":"J Carlson","year":"1992","unstructured":"Carlson J, Ekre H-P, Helmby H, Gysin J, Greenwood BM, Wahlgren M. Disruption of Plasmodium falciparum erythrocyte rosettes by standard heparin and heparin devoid of anticoagulant activity. Am J Trop Med Hyg. 1992;46:595\u2013602.","journal-title":"Am J Trop Med Hyg"},{"key":"290_CR112","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4269\/ajtmh.1994.51.198","volume":"51","author":"SJ Rogerson","year":"1994","unstructured":"Rogerson SJ, Reeder JC, Al-Yaman F, Brown GV. Sulfated glycoconjugates as disrupters of Plasmodium falciparum erythrocyte rosettes. Am J Trop Med Hyg. 1994;51:198\u2013203.","journal-title":"Am J Trop Med Hyg"},{"key":"290_CR113","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1021\/jm701337t","volume":"51","author":"MA Skidmore","year":"2008","unstructured":"Skidmore MA, Dumax-Vorzet AF, Guimond SE, et al. Disruption of rosetting in Plasmodium falciparum malaria with chemically modified heparin and low molecular weight derivatives possessing reduced anticoagulant and other serine protease inhibition activities. J Med Chem. 2008;51:1453\u20138.","journal-title":"J Med Chem"},{"key":"290_CR114","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/infdis\/jiu296","volume":"210","author":"R Chandramohanadas","year":"2014","unstructured":"Chandramohanadas R, Basappa, Russell B, Liew K, Yau YH, Chong A, et al. Small molecule targeting malaria merozoite surface protein-1 (MSP-1) prevents host invasion of divergent plasmodial species. J Infect Dis. 2014;210:1616\u201326.","journal-title":"J Infect Dis"},{"key":"290_CR115","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4155\/fmc.13.53","volume":"5","author":"X Fern\u00e0ndez-Busquets","year":"2013","unstructured":"Fern\u00e0ndez-Busquets X. Heparin-functionalized nanocapsules: enabling targeted delivery of antimalarial drugs. Future Med Chem. 2013;5:737\u20139.","journal-title":"Future Med Chem"},{"key":"290_CR116","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-66-4-807","volume":"66","author":"TW Sheehy","year":"1967","unstructured":"Sheehy TW, Reba RC. Complications of falciparum malaria and their treatment. Ann Intern Med. 1967;66:807\u20139.","journal-title":"Ann Intern Med"},{"key":"290_CR117","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/bmj.1.5751.714","volume":"1","author":"H Smitskamp","year":"1971","unstructured":"Smitskamp H, Wolthuis FH. New concepts in treatment of malignant tertian malaria with cerebral involvement. Br Med J. 1971;1:714\u20136.","journal-title":"Br Med J"},{"key":"290_CR118","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(72)90621-6","volume":"1","author":"N Jaroonvesama","year":"1972","unstructured":"Jaroonvesama N. Intravascular coagulation in falciparum malaria. Lancet. 1972;1:221\u20133.","journal-title":"Lancet"},{"key":"290_CR119","doi-asserted-by":"crossref","first-page":"47","DOI":"10.14238\/pi20.1-2.1980.47-50","volume":"20","author":"M Munir","year":"1980","unstructured":"Munir M, Tjandra H, Rampengan TH, Mustadjab I, Wulur FH. Heparin in the treatment of cerebral malaria. Paediatr Indones. 1980;20:47\u201350.","journal-title":"Paediatr Indones"},{"key":"290_CR120","first-page":"59","volume":"31","author":"TH Rampengan","year":"1991","unstructured":"Rampengan TH. Cerebral malaria in children. Comparative study between heparin, dexamethasone and placebo. Paediatr Indones. 1991;31:59\u201366.","journal-title":"Paediatr Indones"},{"key":"290_CR121","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0035-9203(86)90407-4","volume":"80","author":"World Health Organization Malaria Action Programme","year":"1986","unstructured":"World Health Organization Malaria Action Programme. Severe and complicated malaria. Trans R Soc Trop Med Hyg. 1986;80:3\u201350.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"290_CR122","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jbm.820140508","volume":"14","author":"Y Miura","year":"1980","unstructured":"Miura Y, Aoyagi S, Kusada Y, Miyamoto K. The characteristics of anticoagulation by covalently immobilized heparin. J Biomed Mater Res. 1980;14:619\u201330.","journal-title":"J Biomed Mater Res"},{"key":"290_CR123","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01913274","volume":"1","author":"MA Marchisio","year":"1973","unstructured":"Marchisio MA, Tongo T, Ferruti P. A selective de-heparinizer filter made of new cross-linked polymers of a poly-amido-amine structure. Experientia. 1973;1:93\u20135.","journal-title":"Experientia"},{"key":"290_CR124","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s13346-014-0200-4","volume":"4","author":"VM Joshi","year":"2014","unstructured":"Joshi VM, Devarajan PV. Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand. Drug Deliv Transl Res. 2014;4:353\u201364.","journal-title":"Drug Deliv Transl Res"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-016-0290-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-016-0290-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-016-0290-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T17:45:18Z","timestamp":1748886318000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-016-0290-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,11]]},"references-count":124,"alternative-id":["290"],"URL":"https:\/\/doi.org\/10.1007\/s13346-016-0290-2","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,11]]}}}